过表达MARCH2抑制自噬促进肝细胞癌HUH7细胞的生长
Overexpression of MARCH2 Promotes the Growth of Hepatocellular Carcinoma HUH7 Cells via Inhibiting Autophagy
DOI: 10.12677/acm.2025.1551629, PDF,    科研立项经费支持
作者: 夏 丹*:山东医学高等专科学校病理教研室,山东 临沂;临沂市人民医院病理科,山东 临沂;韦志永:临沂市人民医院病理科,山东 临沂
关键词: MARCH2肝细胞癌HUH7细胞自噬凋亡细胞周期MARCH2 Hepatocellular Carcinoma HUH7 Cell Autophagy Apoptosis Cell Cycle
摘要: 目的:探讨过表达MARCH2对肝细胞癌HUH7细胞自噬水平和生长的影响及其机制。方法:MTS和EDU检测MARCH2过表达的肝细胞癌HUH7细胞的生长情况。流式细胞术检测MARCH2过表达的肝细胞癌HUH7细胞凋亡、细胞周期的情况。Western blot和激光共聚焦法检测MARCH2过表达的肝细胞癌HUH7细胞自噬水平。结果:MTS和EDU检测表明,MARCH2的过表达促进了肝细胞癌HUH7的生长。流式细胞术检测表明,MARCH2过表达对肝细胞癌HUH7细胞凋亡和细胞周期没有明显影响。进一步的实验表明,MARCH2过表达损害了肝细胞癌HUH7的自噬。用常见的自噬诱导剂雷帕霉素挽救自噬可以使肝细胞癌HUH7的增殖率恢复到控制水平。结论:我们的数据表明,MARCH2通过抑制自噬在肿瘤发展过程中起着至关重要的作用。因此,MARCH2是一种有前景的肿瘤治疗新靶点。
Abstract: Aims: To investigate the effects and mechanisms of overexpression of MARCH2 on autophagy levels and growth of hepatocellular carcinoma HUH7 cells. Methods: MTS and EDU were used to detect the growth of MARCH2 overexpressing hepatocellular carcinoma HUH7 cells. Flow cytometry was used to detect apoptosis and cell cycle in MARCH2 overexpressing hepatocellular carcinoma HUH7 cells. Western blot and laser confocal microscopy were used to detect the autophagy levels in MARCH2 overexpressing HUH7 hepatocellular carcinoma cells. Results: In this study, MTS and EDU assays showed that the overexpression of MARCH2 promoted the growth of hepatocellular carcinoma HUH7 cells. Flow cytometry detection illustrated that MARCH2 overexpression had no obvious effect on the hepatocellular carcinoma HUH7 cell apoptosis and cell cycle. Further experiments displayed that MARCH2 overexpression impaired the autophagy of hepatocellular carcinoma HUH7 cells. Rescued autophagy with the common autophagy inducer rapamycin can bring the proliferation rate of hepatocellular carcinoma HUH7 cells back to the control level. Conclusions: Our data indicates that MARCH2 plays an essential role in the progression of tumor development through inhibiting autophagy. Therefore, MARCH2 is an attractive novel target for tumor therapy.
文章引用:夏丹, 韦志永. 过表达MARCH2抑制自噬促进肝细胞癌HUH7细胞的生长[J]. 临床医学进展, 2025, 15(5): 2371-2380. https://doi.org/10.12677/acm.2025.1551629

参考文献

[1] Debnath, J., Gammoh, N. and Ryan, K.M. (2023) Autophagy and Autophagy-Related Pathways in Cancer. Nature Reviews Molecular Cell Biology, 24, 560-575. httpsu//doi.org/10.1038/s41580-023-00585-z
[2] Klionsky, D.J., Petroni, G., Amaravadi, R.K., Baehrecke, E.H., Ballabio, A., Boya, P., et al. (2021) Autophagy in Major Human Diseases. The EMBO Journal, 40, e108863. [Google Scholar] [CrossRef] [PubMed]
[3] Cao, W., Li, J., Yang, K. and Cao, D. (2021) An Overview of Autophagy: Mechanism, Regulation and Research Progress. Bulletin du Cancer, 108, 304-322. [Google Scholar] [CrossRef] [PubMed]
[4] Li, X., He, S. and Ma, B. (2020) Autophagy and Autophagy-Related Proteins in Cancer. Molecular Cancer, 19, Article No. 12. [Google Scholar] [CrossRef] [PubMed]
[5] Rakesh, R., PriyaDharshini, L.C., Sakthivel, K.M. and Rasmi, R.R. (2022) Role and Regulation of Autophagy in Cancer. Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease, 1868, Article ID: 166400. [Google Scholar] [CrossRef] [PubMed]
[6] Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[7] 舒宏. AFP阴性肝癌早期诊断的蛋白分子标志物[J]. 中国实验诊断学, 2022, 26(7): 1090-1093.
[8] Xing, M., Wang, X., Kirken, R., He, L. and Zhang, J. (2021) Immunodiagnostic Biomarkers for Hepatocellular Carcinoma (HCC): The First Step in Detection and Treatment. International Journal of Molecular Sciences, 22, Article 6139. [Google Scholar] [CrossRef] [PubMed]
[9] Li, Q., Ni, Y., Zhang, L., Jiang, R., Xu, J., Yang, H., et al. (2021) Hif-1α-induced Expression of M6a Reader YTHDF1 Drives Hypoxia-Induced Autophagy and Malignancy of Hepatocellular Carcinoma by Promoting ATG2A and ATG14 Translation. Signal Transduction and Targeted Therapy, 6, Article No. 76. [Google Scholar] [CrossRef] [PubMed]
[10] Yao, J., Wang, J., Xu, Y., Guo, Q., Sun, Y., Liu, J., et al. (2021) CDK9 Inhibition Blocks the Initiation of Pink1-Prkn-Mediated Mitophagy by Regulating the SIRT1-FOXO3-BNIP3 Axis and Enhances the Therapeutic Effects Involving Mitochondrial Dysfunction in Hepatocellular Carcinoma. Autophagy, 18, 1879-1897. [Google Scholar] [CrossRef] [PubMed]
[11] Zheng, Y., Huang, C., Lu, L., Yu, K., Zhao, J., Chen, M., et al. (2021) STOML2 Potentiates Metastasis of Hepatocellular Carcinoma by Promoting Pink1-Mediated Mitophagy and Regulates Sensitivity to Lenvatinib. Journal of Hematology & Oncology, 14, Article No. 16. [Google Scholar] [CrossRef] [PubMed]
[12] Han, Z., Liu, D., Chen, L., He, Y., Tian, X., Qi, L., et al. (2021) PNO1 Regulates Autophagy and Apoptosis of Hepatocellular Carcinoma via the MAPK Signaling Pathway. Cell Death & Disease, 12, Article No. 552. [Google Scholar] [CrossRef] [PubMed]
[13] Desideri, E., Castelli, S., Dorard, C., Toifl, S., Grazi, G.L., Ciriolo, M.R., et al. (2022) Impaired Degradation of YAP1 and IL6ST by Chaperone-Mediated Autophagy Promotes Proliferation and Migration of Normal and Hepatocellular Carcinoma Cells. Autophagy, 19, 152-162. [Google Scholar] [CrossRef] [PubMed]
[14] Yu, Z., Guo, J., Hu, M., et al. (2020) Icaritin Exacerbates Mitophagy and Synergizes with Doxorubicin to Induce Immunogenic Cell Death in Hepatocellular Carcinoma. ACS Nano, 14, 4816-4828.
[15] 赵远波, 洪杜北琦, 陈英玉. 基于p62/SQSTM1-luciferase的细胞自噬水平检测方法的建立及鉴定[J]. 中国生物工程杂志, 2016, 36(1): 55-62.
[16] Takamura, A., Komatsu, M., Hara, T., Sakamoto, A., Kishi, C., Waguri, S., et al. (2011) Autophagy-Deficient Mice Develop Multiple Liver Tumors. Genes & Development, 25, 795-800. [Google Scholar] [CrossRef] [PubMed]
[17] Inami, Y., Waguri, S., Sakamoto, A., Kouno, T., Nakada, K., Hino, O., et al. (2011) Persistent Activation of Nrf2 through p62 in Hepatocellular Carcinoma Cells. Journal of Cell Biology, 193, 275-284. [Google Scholar] [CrossRef] [PubMed]
[18] White, E. (2015) The Role for Autophagy in Cancer. Journal of Clinical Investigation, 125, 42-46. [Google Scholar] [CrossRef] [PubMed]
[19] Mathew, R., Karp, C.M., Beaudoin, B., Vuong, N., Chen, G., Chen, H., et al. (2009) Autophagy Suppresses Tumorigenesis through Elimination of p62. Cell, 137, 1062-1075. [Google Scholar] [CrossRef] [PubMed]
[20] Qian, H. and Yang, Y. (2016) Functional Role of Autophagy in Gastric Cancer. Oncotarget, 7, 17641-17651. [Google Scholar] [CrossRef] [PubMed]
[21] Li, L., Shen, C., Nakamura, E., et al. (2013) SQSTM1 Is a Pathogenic Target of 5q Copy Number Gains in Kidney Cancer. Cancer Cell, 24, 738-750.
[22] Duran, A., Linares, J.F., Galvez, A.S., Wikenheiser, K., Flores, J.M., Diaz-Meco, M.T., et al. (2008) The Signaling Adaptor p62 Is an Important NF-κB Mediator in Tumorigenesis. Cancer Cell, 13, 343-354. [Google Scholar] [CrossRef] [PubMed]
[23] Yu, S., Li, G., Wang, Z., Wang, Z., Chen, C., Cai, S., et al. (2016) Low Expression of MAP1LC3B, Associated with Low Beclin-1, Predicts Lymph Node Metastasis and Poor Prognosis of Gastric Cancer. Tumor Biology, 37, 15007-15017. [Google Scholar] [CrossRef] [PubMed]
[24] Degenhardt, K., Mathew, R., Beaudoin, B., Bray, K., Anderson, D., Chen, G., et al. (2006) Autophagy Promotes Tumor Cell Survival and Restricts Necrosis, Inflammation, and Tumorigenesis. Cancer Cell, 10, 51-64. [Google Scholar] [CrossRef] [PubMed]
[25] Guo, J.Y., Chen, H., Mathew, R., Fan, J., Strohecker, A.M., Karsli-Uzunbas, G., et al. (2011) Activated Ras Requires Autophagy to Maintain Oxidative Metabolism and Tumorigenesis. Genes & Development, 25, 460-470. [Google Scholar] [CrossRef] [PubMed]
[26] Lock, R., Roy, S., Kenific, C.M., Su, J.S., Salas, E., Ronen, S.M., et al. (2011) Autophagy Facilitates Glycolysis during Ras-Mediated Oncogenic Transformation. Molecular Biology of the Cell, 22, 165-178. [Google Scholar] [CrossRef] [PubMed]
[27] Yang, S., Wang, X., Contino, G., Liesa, M., Sahin, E., Ying, H., et al. (2011) Pancreatic Cancers Require Autophagy for Tumor Growth. Genes & Development, 25, 717-729. [Google Scholar] [CrossRef] [PubMed]
[28] Lock, R., Kenific, C.M., Leidal, A.M., et al. (2014) Autophagy-Dependent Production of Secreted Factors Facilitates Oncogenic RAS-Driven Invasion. Cancer Discovery, 4, 466-479.
[29] Guo, J.Y., Xia, B. and White, E. (2013) Autophagy-Mediated Tumor Promotion. Cell, 155, 1216-1219. [Google Scholar] [CrossRef] [PubMed]